- Home
- LTBR vs CCEL Comparison
LTBR vs CCEL Comparison
Compare LTBR & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTBR
- CCEL
- Stock Information
- Founded
- LTBR 1992
- CCEL 1989
- Country
- LTBR United States
- CCEL United States
- Employees
- LTBR N/A
- CCEL N/A
- Industry
- LTBR Professional Services
- CCEL Managed Health Care
- Sector
- LTBR Consumer Discretionary
- CCEL Health Care
- Exchange
- LTBR Nasdaq
- CCEL Nasdaq
- Market Cap
- LTBR 45.5M
- CCEL 50.0M
- IPO Year
- LTBR N/A
- CCEL 1997
- Fundamental
- Price
- LTBR $8.03
- CCEL $7.60
- Analyst Decision
- LTBR
- CCEL
- Analyst Count
- LTBR 0
- CCEL 0
- Target Price
- LTBR N/A
- CCEL N/A
- AVG Volume (30 Days)
- LTBR 2.0M
- CCEL 13.0K
- Earning Date
- LTBR 02-26-2025
- CCEL 02-26-2025
- Dividend Yield
- LTBR N/A
- CCEL 3.35%
- EPS Growth
- LTBR N/A
- CCEL N/A
- EPS
- LTBR N/A
- CCEL N/A
- Revenue
- LTBR N/A
- CCEL $31,838,476.00
- Revenue This Year
- LTBR N/A
- CCEL $3.97
- Revenue Next Year
- LTBR N/A
- CCEL $0.91
- P/E Ratio
- LTBR N/A
- CCEL N/A
- Revenue Growth
- LTBR N/A
- CCEL 1.95
- 52 Week Low
- LTBR $2.21
- CCEL $4.47
- 52 Week High
- LTBR $14.20
- CCEL $9.50
- Technical
- Relative Strength Index (RSI)
- LTBR 59.94
- CCEL 50.66
- Support Level
- LTBR $5.12
- CCEL $6.74
- Resistance Level
- LTBR $10.45
- CCEL $7.69
- Average True Range (ATR)
- LTBR 1.08
- CCEL 0.37
- MACD
- LTBR 0.39
- CCEL 0.05
- Stochastic Oscillator
- LTBR 55.51
- CCEL 73.50
About LTBR Lightbridge Corporation
Lightbridge Corp is a United States-based nuclear fuel technology company. The business activity of the firm is functioned through Nuclear Fuel Technology segment. The Nuclear Fuel Technology segment develops next generation nuclear fuel technology that increases the power output of commercial reactors and reduces the cost of generating electricity. Geographically, its operations are functioned through the region of Unites States.
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from cellular processing and cryogenic storage and it derives revenue from processing and testing fees and storage segment.